PD-1/PD-L1-IN-42 (Compound B8.4) is an inhibitor of the PD-1/PD-L1 interaction, with an EC50 of 0.1 µM. It is applicable in cancer immunotherapy research.
Formula:
C85H129N21O24S
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
